Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

CordenPharma and Viking Therapeutics sign multi-year strategic partnership to support the commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735.CordenPharma provides large-scale ...

Despite their tremendous potential, peptide therapeutics face ongoing challenges. Their relatively short half-life in the body necessitates frequent dosing or specialized delivery systems.

Pediatric doses associated with consistent exposure across age are still unknown. Therefore, we aim to identify a dosing strategy for ivermectin treatment in both pre-school-aged children (2–5 years ...

The Danish drugmaker said the new price could appeal to the uninsured and those whose insurance doesn't cover the class of obesity medications called GLP-1, or glucagon-like peptide-1, medications.

Zepbound belongs to a group of drugs called dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP ... basics of Zepbound’s dosing schedule when ...

Quercetin has most often been used by adults in doses of 250-1000 mg by mouth daily for up to 12 weeks. Speak with a healthcare provider to find out what dose might be best for a specific condition.

Wegovy belongs to a group of drugs called glucagon-like peptide-1 (GLP-1 ... Note: This chart highlights the basics of Wegovy’s dosage in milligrams (mg). You can then read on for more details.

Ozempic is a brand-name, glucagon-like peptide-1 (GLP-1) receptor agonist. It's available in a prefilled pen to inject the liquid dosage under the skin. In addition to managing blood sugar, Ozempic ...

That's not all. Metsera's GLP-1 peptide also has a long half-life, which could allow for monthly dosing, a more convenient administration system than the current approved drugs, which require ...